Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ben Li
Observed name:
Li, Ben
Institution:
Affiliated Hospital of Qingdao University
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Affiliated Hospital of Qingdao University,
Affiliated Hospital of Hebei University,
Hebei University,
MSD (China) Investment Co., Ltd. (China),
Guangzhou Medical University
show all 6
ORCID:
0009-0006-7523-0144
Observed ORCIDs:
0009-0006-7523-0144,
0000-0002-3707-4236
OpenAlex ID:
A5100355580
KEYNOTE ‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive , advanced NSCLC
2023
·
Shengxiang Ren
, Jifeng Feng
, et al.
·
International Journal of Cancer
·
67
PDF
Icaritin-loaded PLGA nanoparticles activate immunogenic cell death and facilitate tumor recruitment in mice with gastric cancer
2022
·
Yao Xiao
, Wenxia Yao
, et al.
·
Drug Delivery
·
56
PDF
KEYNOTE-921: Phase III Study of Pembrolizumab Plus Docetaxel for Metastatic Castration-Resistant Prostate Cancer
2021
·
Daniel P Petrylak
, Raffaele Ratta
, et al.
·
Future Oncology
·
51
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients
2021
·
Jie Yang
, Hefei Li
, et al.
·
Frontiers in Oncology
·
28
PDF
Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening
2023
·
Ben Li
, Shanglong Liu
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
18
PDF
Clinical outcomes and safety of osimertinib plus anlotinib for patients with previously treated EGFR T790M‐positive NSCLC: A retrospective study
2022
·
Bin Zhou
, Qiang Gong
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
14
Expression and clinical significance of serum 25-OH-D in pregnant women with SCH (Subclinical Hypothyroidism) and GDM (Gestational Diabetes Mellitus)
2018
·
Xue Zhou
, Zhihong Li
, et al.
·
Pakistan Journal of Medical Sciences
·
8
PDF
Al18F-NOTA-HER2-BCH versus 18F-FDG PET/CT in evaluating newly diagnosed HER2-low breast cancer patients
2025
·
Xiaoyi Guo
, Xu Liang
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
7
Phase III study of pembrolizumab (pembro) plus docetaxel and prednisone for enzalutamide (enza)- or abiraterone acetate (abi)–pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-921.
2020
·
Daniel Peter Petrylak
, Neal D. Shore
, et al.
·
Journal of Clinical Oncology
·
6
Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report
2022
·
Bin Zhou
, Yanan Wang
, et al.
·
Medicine
·
4
A prospective head-to-head comparison of 18F-NYM005 PET/CT and 18F-FDG PET/CT in diagnosing renal cell carcinoma
2026
·
Pei Nie
, Ben Li
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
3
Real-world clinical outcomes of anticancer treatments and prognostic factors in patients with advanced melanoma in China
2020
·
Chuanliang Cui
, Xieqiao Yan
, et al.
·
International Journal of Surgery Oncology
·
3
Quinoline/Naphthalene-Embedded PSMA Probes for Precise PET Imaging with Minimized Undesired Retention
2026
·
Zhexin He
, Hongwu Liu
, et al.
·
Journal of Medicinal Chemistry
·
2
18F-FAPI PET/CT and Cardiac Magnetic Resonance for Cardiac Fibrotic Process in End-stage Renal Disease: A Pilot Study
2026
·
Tairui Wu
, Congjuan Luo
, et al.
·
Clinical Nuclear Medicine
[ 18 F] F-NYM124 for safety, imaging, and dosimetry in patients with indeterminate renal masses.
2026
·
Guangjie Yang
, Ben Li
, et al.
·
Journal of Clinical Oncology
PDF
Al18F-NOTA-HER2-BCH PET/MR for regional lymph node metastasis assessment in HER2-low and -positive breast cancer: a prospective study
2026
·
Hongmin Yang
, Xiaoyi Guo
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
The Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer and Its Relationship with Tumor Markers
2022
·
Rongfang Liu
, Ben Li
, et al.
·
Proceedings of Anticancer Research
PDF
343 Phase 3 study of pembrolizumab + docetaxel and prednisone/prednisolone for metastatic castration-resistant prostate cancer (mCRPC) pretreated with next-generation hormonal agents (NHAs) (KEYNOTE-921)
2020
·
Daniel Petrylak
, Neal Shore
, et al.
·
Journal for ImmunoTherapy of Cancer
Show more works
View as search
Works count:
19
Citation count:
267
H-index:
7
I10-index:
6
Year
Topic
Type